A meta-analysis has suggested that individuals with BRCA1 mutations have a higher risk of developing CRC, but the risk is not higher for those with BRCA2 mutations; However, the findings of this study are subject to debate 35. This evidence concerns the gene BRCA2 and colorectal carcinoma.